AFRY Management Consulting has released a report titled Factors for the Siting of Biorefineries for the CSA Group, providing crucial insights int ...

Sanofi has completed the sale of a 50.0% controlling stake in its consumer healthcare division, Opella, to CD&R, creating a global leader in ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to ...

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R of a 50.0% controlling ...

Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of ...

Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in French pharma major Sanofi's strategy. Sanofi announced today the closing of the sale to US private ...

RESEARCH TRIANGLE PARK, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today ...

Opella Enterogermina challenges Murphy's Law which states that “anything that can go wrong, will go wrong” and questions the ...

Celebrate New Jersey’s top real estate, construction and design leaders at the NJBIZ awards June 10. Honorees include top firms and projects.

Enterogermina, the leading brand in the probiotic segment and part of Opella, Sanofi's Consumer Healthcare business unit, has launched a campaign that playfully challenges the laws of physics: The ...